Thorne HealthTech, Inc.

Thorne HealthTech, Inc. (Nasdaq: THRN), relating to its proposed sale to L. Catterton. Under the terms of the agreement, THRN shareholders are expected to receive $10.20 in cash per share they own.

To receive more information regarding the investigation of Thorne HealthTech, Inc. please fill out the form below.